Source map — Biogen makes up to $1B deal for secretive anti-inflammatory biotech
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Endpoints News | news | 60% |
| Fierce Biotech | news | 60% |
| Reuters | news | 60% |
| FirstWord Pharma | news | 60% |
| BioPharma Dive | news | 60% |
| Biogen | news | 60% |
| markets.businessinsider.com | news | 60% |
| biobriefs.com | news | 50% |
| updates.biomednexus.com | news | 50% |
| briefpharma.com | news | 50% |
| www.newsbreak.com | news | 50% |
| www.quiverquant.com | news | 50% |
| finance.yahoo.com | news | 50% |
| www.bio-itworld.com | news | 50% |
| www.manilatimes.net | news | 50% |
| www.stocktitan.net | news | 50% |
| www.biotech-now.co.uk | news | 50% |
| www.talk.bio | news | 50% |
| www.edgen.tech | news | 50% |
| allsci.com | news | 50% |
| www.biospace.com | news | 50% |
| www.fiercebiotech.com | news | 50% |
| hoodline.com | news | 50% |